Ocular Manifestation and Related Risk Factors of Covid-19 Associated Mucormycosis: a Multicenter Study in Iran

Summary

Coronavirus disease 2019 (COVID-19) infection caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may manifest as a variety of disease patterns, ranging from mild to life-threatening pneumonia.

Mucormycosis has been suspected to cause significant morbidity in infected people since the outbreak of the COVID-19 pandemic. Individuals who require hospitalization and intensive care are more vulnerable, as they have reached an advanced stage of their disease. Investigators will discuss the major risk factors, ocular presentation, and outcome of mucormycosis in individuals infected with SARS-CoV-2 in this study. From August 2021 to January 2022, a cross-sectional descriptive multicenter investigation would be conducted on patients with biopsy-confirmed mucormycosis and RTPCR confirmed COVID19. Demographic data, the time interval between COVID19 and mucormycosis, underlying systemic disorders, clinical characteristics, disease course, and outcomes would be analyzed.

Conditions

• COVID-19
• Mucormycosis

Sponsors & Collaborators

• Shiraz University of Medical Sciences

  collaborator OTHER

• Ahvaz Jundishapur University of Medical Sciences

  collaborator OTHER

• Iran University of Medical Sciences

  collaborator OTHER

• Mashhad University of Medical Sciences

  collaborator OTHER

• Tabriz University of Medical Sciences

  collaborator OTHER

• Guilan University of Medical Sciences

  collaborator OTHER

• Kermanshah University of Medical Sciences

  collaborator OTHER

• Shahid Beheshti University of Medical Sciences

  collaborator OTHER

• Semnan University of Medical Sciences

  collaborator OTHER

• Isfahan University of Medical Sciences

  lead OTHER

Principal Investigators

• Mohsen Pourazizi, M.D. · Isfahan Eye Research Center

Eligibility

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2021-08-23

Primary Completion

2021-11-21

Completion

2022-01-20

Countries

• Iran

Study Locations